Related Experiment Video
Updated: Oct 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Assessment and management of persons coinfected with tuberculosis and human immunodeficiency virus
1Hawaii AIDS Clinical Trials Unit, Honolulu.
Abstract:
After eight decades of decline, cases of tuberculosis (TB) have increased substantially since 1985. This increase is attributed largely to a reactivation of disease in persons who are coinfected with TB and human immunodeficiency virus (HIV). Multiple-drug resistant tuberculosis (MDR-TB) has a high mortality rate (70 to 90%), mostly occurring in individuals with HIV. Death often results within 4 to 16 weeks of diagnosis. The pathogenesis, screening, chemoprophylaxis, diagnosis, and treatment of persons coinfected TB and HIV is reviewed. Attention is given to infection control and occupational exposure. A chart of commonly prescribed antituberculosis medications is listed, including recommended adult dosages, side effects, and drug interactions. Clinicians must incorporate meticulous TB screening and treatment for all patients coinfected with HIV and TB.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis